Co-Authors
This is a "connection" page, showing publications co-authored by Danny Dhanasekaran and Revathy Nadhan.
Connection Strength
5.259
-
Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks. Signal Transduct Target Ther. 2025 Oct 10; 10(1):337.
Score: 0.969
-
Optimizing lncRNA-miRNA interaction analysis: Modified crosslinking and immunoprecipitation (M-CLIP) assay. MethodsX. 2024 Dec; 13:103028.
Score: 0.907
-
LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential. Cancer Lett. 2024 Oct 16; 217297.
Score: 0.905
-
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies. Metabolites. 2023 Apr 30; 13(5).
Score: 0.817
-
Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. Cells. 2022 08 13; 11(16).
Score: 0.778
-
LncRNAs at the Crossroads of Precision Nutrition and Cancer Chemoprevention. Cancers (Basel). 2026 Jan 29; 18(3).
Score: 0.247
-
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications. Cancers (Basel). 2025 Jan 30; 17(3).
Score: 0.231
-
Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
Score: 0.219
-
Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells. Biomedicines. 2021 Dec 16; 9(12).
Score: 0.186